Gene Symbol | Gene ID | Gene Info |
---|---|---|
MECP2
|
ENSG00000169057.15 | methyl-CpG binding protein 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_153329483_153329634 | MECP2 | 32878 | 0.095575 | -0.59 | 9.3e-02 | Click! |
chrX_153342525_153342676 | MECP2 | 19836 | 0.121953 | -0.53 | 1.4e-01 | Click! |
chrX_153358386_153358537 | MECP2 | 3975 | 0.171749 | 0.38 | 3.1e-01 | Click! |
chrX_153359472_153359623 | MECP2 | 2889 | 0.199205 | 0.35 | 3.6e-01 | Click! |
chrX_153362983_153363134 | MECP2 | 90 | 0.959816 | 0.34 | 3.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_35102956_35103650 | 3.37 |
PARD3 |
par-3 family cell polarity regulator |
946 |
0.5 |
chr22_34315378_34316336 | 2.76 |
LARGE |
like-glycosyltransferase |
469 |
0.83 |
chr3_64430574_64431219 | 2.67 |
PRICKLE2 |
prickle homolog 2 (Drosophila) |
162 |
0.97 |
chr12_106533400_106533896 | 2.67 |
NUAK1 |
NUAK family, SNF1-like kinase, 1 |
163 |
0.97 |
chr6_133562881_133563193 | 2.58 |
EYA4 |
eyes absent homolog 4 (Drosophila) |
268 |
0.95 |
chr4_148402008_148402467 | 2.46 |
EDNRA |
endothelin receptor type A |
153 |
0.97 |
chr7_100660155_100661047 | 2.42 |
RP11-395B7.4 |
|
281 |
0.85 |
chr17_12693066_12693649 | 2.42 |
RP11-1090M7.1 |
|
202 |
0.59 |
chr1_16085392_16086186 | 2.41 |
FBLIM1 |
filamin binding LIM protein 1 |
497 |
0.68 |
chr3_126702505_126703684 | 2.41 |
PLXNA1 |
plexin A1 |
4343 |
0.34 |
chr9_104248314_104249564 | 2.37 |
TMEM246 |
transmembrane protein 246 |
460 |
0.79 |
chr19_55795582_55795793 | 2.36 |
BRSK1 |
BR serine/threonine kinase 1 |
102 |
0.92 |
chr22_48885421_48885737 | 2.33 |
FAM19A5 |
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 |
175 |
0.97 |
chr7_557332_557625 | 2.27 |
PDGFA |
platelet-derived growth factor alpha polypeptide |
667 |
0.72 |
chr18_57364074_57364448 | 2.27 |
CCBE1 |
collagen and calcium binding EGF domains 1 |
351 |
0.64 |
chr16_75299159_75299651 | 2.26 |
BCAR1 |
breast cancer anti-estrogen resistance 1 |
292 |
0.87 |
chr7_73868670_73869167 | 2.24 |
GTF2IRD1 |
GTF2I repeat domain containing 1 |
479 |
0.83 |
chr1_6545321_6545520 | 2.22 |
PLEKHG5 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
109 |
0.94 |
chr3_159482295_159482916 | 2.21 |
IQCJ-SCHIP1 |
IQCJ-SCHIP1 readthrough |
287 |
0.9 |
chr10_123872502_123872999 | 2.19 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
196 |
0.97 |
chr2_127976513_127977351 | 2.19 |
CYP27C1 |
cytochrome P450, family 27, subfamily C, polypeptide 1 |
722 |
0.74 |
chr1_240256340_240256520 | 2.18 |
FMN2 |
formin 2 |
1250 |
0.57 |
chr2_205410516_205411018 | 2.18 |
PARD3B |
par-3 family cell polarity regulator beta |
44 |
0.99 |
chr4_187644173_187644789 | 2.16 |
FAT1 |
FAT atypical cadherin 1 |
528 |
0.87 |
chr21_47401799_47402727 | 2.16 |
COL6A1 |
collagen, type VI, alpha 1 |
612 |
0.75 |
chr22_43115644_43116713 | 2.15 |
A4GALT |
alpha 1,4-galactosyltransferase |
24539 |
0.15 |
chr2_75787847_75788044 | 2.15 |
EVA1A |
eva-1 homolog A (C. elegans) |
94 |
0.97 |
chr10_123922760_123923208 | 2.14 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
43 |
0.99 |
chr5_83680091_83680703 | 2.13 |
CTD-2269F5.1 |
|
23 |
0.71 |
chr2_133427462_133427743 | 2.12 |
LYPD1 |
LY6/PLAUR domain containing 1 |
176 |
0.96 |
chr17_59476045_59476898 | 2.11 |
RP11-332H18.4 |
|
260 |
0.74 |
chr4_183066125_183066448 | 2.11 |
AC108142.1 |
|
116 |
0.64 |
chr16_51184635_51185066 | 2.10 |
SALL1 |
spalt-like transcription factor 1 |
302 |
0.89 |
chr12_81471441_81472090 | 2.09 |
ACSS3 |
acyl-CoA synthetase short-chain family member 3 |
71 |
0.98 |
chr6_39901861_39902276 | 2.07 |
MOCS1 |
molybdenum cofactor synthesis 1 |
92 |
0.98 |
chr17_70117213_70117669 | 2.06 |
SOX9 |
SRY (sex determining region Y)-box 9 |
280 |
0.95 |
chr12_28123391_28123945 | 2.02 |
PTHLH |
parathyroid hormone-like hormone |
386 |
0.88 |
chr21_42539308_42539931 | 2.02 |
BACE2 |
beta-site APP-cleaving enzyme 2 |
109 |
0.53 |
chr8_41511279_41511901 | 2.00 |
NKX6-3 |
NK6 homeobox 3 |
2735 |
0.18 |
chr1_32169382_32169651 | 1.99 |
COL16A1 |
collagen, type XVI, alpha 1 |
252 |
0.9 |
chr2_85361374_85361661 | 1.99 |
TCF7L1 |
transcription factor 7-like 1 (T-cell specific, HMG-box) |
984 |
0.59 |
chr22_37956672_37957106 | 1.98 |
CDC42EP1 |
CDC42 effector protein (Rho GTPase binding) 1 |
402 |
0.77 |
chr17_39969274_39969651 | 1.97 |
FKBP10 |
FK506 binding protein 10, 65 kDa |
279 |
0.68 |
chr21_43373453_43373856 | 1.96 |
C2CD2 |
C2 calcium-dependent domain containing 2 |
345 |
0.88 |
chr12_106532817_106533194 | 1.96 |
NUAK1 |
NUAK family, SNF1-like kinase, 1 |
806 |
0.7 |
chr15_71145930_71146354 | 1.96 |
LARP6 |
La ribonucleoprotein domain family, member 6 |
205 |
0.72 |
chr9_138372016_138372571 | 1.95 |
PPP1R26-AS1 |
PPP1R26 antisense RNA 1 |
271 |
0.72 |
chr16_65155038_65155536 | 1.94 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
546 |
0.88 |
chr15_68871678_68872325 | 1.93 |
CORO2B |
coronin, actin binding protein, 2B |
428 |
0.9 |
chr6_105627392_105627796 | 1.93 |
POPDC3 |
popeye domain containing 3 |
141 |
0.93 |
chr22_28196352_28196977 | 1.91 |
MN1 |
meningioma (disrupted in balanced translocation) 1 |
822 |
0.72 |
chr11_131780761_131781452 | 1.90 |
NTM |
neurotrimin |
209 |
0.95 |
chr18_25757173_25757741 | 1.90 |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
47 |
0.99 |
chr20_19738874_19739407 | 1.90 |
AL121761.2 |
Uncharacterized protein |
461 |
0.85 |
chr3_52567337_52567575 | 1.88 |
NT5DC2 |
5'-nucleotidase domain containing 2 |
91 |
0.94 |
chr3_125985987_125986785 | 1.86 |
ALDH1L1-AS2 |
ALDH1L1 antisense RNA 2 |
60288 |
0.1 |
chr6_154830586_154831325 | 1.86 |
CNKSR3 |
CNKSR family member 3 |
838 |
0.76 |
chr14_23450829_23451172 | 1.83 |
AJUBA |
ajuba LIM protein |
205 |
0.66 |
chr22_48885838_48886065 | 1.82 |
FAM19A5 |
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 |
547 |
0.85 |
chr3_110791230_110791852 | 1.82 |
PVRL3 |
poliovirus receptor-related 3 |
526 |
0.71 |
chr1_48462552_48463006 | 1.81 |
TRABD2B |
TraB domain containing 2B |
212 |
0.96 |
chr10_118500836_118501537 | 1.80 |
HSPA12A |
heat shock 70kDa protein 12A |
899 |
0.64 |
chr5_9544908_9545592 | 1.80 |
SEMA5A |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
937 |
0.56 |
chr7_100798073_100798781 | 1.80 |
AP1S1 |
adaptor-related protein complex 1, sigma 1 subunit |
621 |
0.54 |
chr7_33945201_33945548 | 1.79 |
BMPER |
BMP binding endothelial regulator |
229 |
0.96 |
chr9_72658914_72659269 | 1.78 |
MAMDC2 |
MAM domain containing 2 |
594 |
0.81 |
chr22_36424159_36424401 | 1.77 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
193 |
0.97 |
chr15_48010424_48010678 | 1.77 |
SEMA6D |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
107 |
0.98 |
chr5_131593477_131594185 | 1.77 |
PDLIM4 |
PDZ and LIM domain 4 |
431 |
0.81 |
chr11_118492062_118492969 | 1.77 |
PHLDB1 |
pleckstrin homology-like domain, family B, member 1 |
14157 |
0.11 |
chr14_30395937_30396406 | 1.77 |
PRKD1 |
protein kinase D1 |
677 |
0.76 |
chr5_178771678_178772082 | 1.77 |
ADAMTS2 |
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
551 |
0.84 |
chr3_147111438_147111670 | 1.75 |
ZIC1 |
Zic family member 1 |
128 |
0.96 |
chr13_110958781_110959436 | 1.74 |
COL4A1 |
collagen, type IV, alpha 1 |
370 |
0.6 |
chr2_45395914_45396553 | 1.73 |
SIX2 |
SIX homeobox 2 |
159664 |
0.04 |
chr15_73976688_73977423 | 1.73 |
CD276 |
CD276 molecule |
17 |
0.98 |
chr4_189203647_189204041 | 1.72 |
RP11-366H4.3 |
|
139311 |
0.05 |
chr10_73723658_73723949 | 1.71 |
CHST3 |
carbohydrate (chondroitin 6) sulfotransferase 3 |
320 |
0.92 |
chr19_4584366_4584890 | 1.70 |
SEMA6B |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B |
24808 |
0.09 |
chr12_58131565_58131773 | 1.70 |
AGAP2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
50 |
0.92 |
chr22_50744615_50744936 | 1.70 |
PLXNB2 |
plexin B2 |
1242 |
0.27 |
chr16_10673983_10674206 | 1.69 |
EMP2 |
epithelial membrane protein 2 |
461 |
0.78 |
chr16_10276697_10276872 | 1.69 |
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
173 |
0.97 |
chr1_224803774_224804760 | 1.68 |
CNIH3 |
cornichon family AMPA receptor auxiliary protein 3 |
272 |
0.57 |
chr1_117453113_117453757 | 1.68 |
PTGFRN |
prostaglandin F2 receptor inhibitor |
756 |
0.65 |
chr19_30717249_30717620 | 1.67 |
ZNF536 |
zinc finger protein 536 |
1987 |
0.34 |
chr14_23776071_23776801 | 1.65 |
BCL2L2-PABPN1 |
BCL2L2-PABPN1 readthrough |
260 |
0.45 |
chr10_79396627_79397649 | 1.63 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
67 |
0.98 |
chr13_40176285_40177298 | 1.62 |
LHFP |
lipoma HMGIC fusion partner |
517 |
0.82 |
chr21_38338313_38338658 | 1.62 |
HLCS |
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) |
288 |
0.9 |
chr6_128840723_128841590 | 1.62 |
PTPRK |
protein tyrosine phosphatase, receptor type, K |
347 |
0.86 |
chr18_33877761_33878158 | 1.62 |
FHOD3 |
formin homology 2 domain containing 3 |
160 |
0.97 |
chr2_128433072_128433763 | 1.61 |
LIMS2 |
LIM and senescent cell antigen-like domains 2 |
557 |
0.72 |
chr5_107005011_107005570 | 1.61 |
EFNA5 |
ephrin-A5 |
1038 |
0.67 |
chr16_65154751_65155029 | 1.61 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
943 |
0.75 |
chr6_105584147_105584651 | 1.61 |
BVES |
blood vessel epicardial substance |
161 |
0.57 |
chr19_45931964_45932396 | 1.59 |
ERCC1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
288 |
0.84 |
chr1_2005099_2005545 | 1.58 |
PRKCZ |
protein kinase C, zeta |
103 |
0.96 |
chr15_68723666_68723936 | 1.58 |
ITGA11 |
integrin, alpha 11 |
691 |
0.79 |
chr5_175793030_175793335 | 1.58 |
ARL10 |
ADP-ribosylation factor-like 10 |
711 |
0.45 |
chr1_223900690_223901533 | 1.58 |
CAPN2 |
calpain 2, (m/II) large subunit |
1077 |
0.55 |
chr15_39873424_39874712 | 1.57 |
THBS1 |
thrombospondin 1 |
774 |
0.66 |
chr19_34973190_34973467 | 1.57 |
WTIP |
Wilms tumor 1 interacting protein |
105 |
0.96 |
chr14_38063567_38064244 | 1.57 |
FOXA1 |
forkhead box A1 |
334 |
0.84 |
chr1_66258526_66259233 | 1.56 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
15 |
0.99 |
chr22_18958043_18958414 | 1.56 |
DGCR5 |
DiGeorge syndrome critical region gene 5 (non-protein coding) |
132 |
0.96 |
chr16_75298860_75299117 | 1.56 |
BCAR1 |
breast cancer anti-estrogen resistance 1 |
125 |
0.95 |
chr10_128594353_128594780 | 1.55 |
DOCK1 |
dedicator of cytokinesis 1 |
588 |
0.8 |
chr10_128593547_128593773 | 1.55 |
DOCK1 |
dedicator of cytokinesis 1 |
318 |
0.92 |
chr2_9347772_9348251 | 1.55 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
1117 |
0.65 |
chr17_37856067_37857084 | 1.55 |
ERBB2 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 |
242 |
0.86 |
chr5_174152116_174152407 | 1.55 |
MSX2 |
msh homeobox 2 |
656 |
0.79 |
chr1_33167770_33168186 | 1.54 |
SYNC |
syncoilin, intermediate filament protein |
383 |
0.81 |
chr1_64240383_64241287 | 1.54 |
ROR1 |
receptor tyrosine kinase-like orphan receptor 1 |
1121 |
0.63 |
chr11_27721482_27721925 | 1.54 |
BDNF |
brain-derived neurotrophic factor |
332 |
0.92 |
chrX_107069559_107069961 | 1.54 |
MID2 |
midline 2 |
116 |
0.97 |
chr2_127864060_127864514 | 1.53 |
BIN1 |
bridging integrator 1 |
290 |
0.94 |
chr10_73724084_73724979 | 1.53 |
CHST3 |
carbohydrate (chondroitin 6) sulfotransferase 3 |
408 |
0.89 |
chr1_31380843_31381078 | 1.53 |
SDC3 |
syndecan 3 |
648 |
0.66 |
chr10_128076215_128076453 | 1.53 |
ADAM12 |
ADAM metallopeptidase domain 12 |
690 |
0.79 |
chr5_15500636_15500842 | 1.52 |
FBXL7 |
F-box and leucine-rich repeat protein 7 |
434 |
0.91 |
chr9_132382165_132382732 | 1.52 |
C9orf50 |
chromosome 9 open reading frame 50 |
607 |
0.62 |
chr18_33878368_33878633 | 1.52 |
FHOD3 |
formin homology 2 domain containing 3 |
701 |
0.78 |
chr10_61469364_61469637 | 1.51 |
SLC16A9 |
solute carrier family 16, member 9 |
337 |
0.94 |
chr1_236227370_236227967 | 1.51 |
NID1 |
nidogen 1 |
741 |
0.67 |
chr17_41723221_41723932 | 1.50 |
MEOX1 |
mesenchyme homeobox 1 |
15355 |
0.17 |
chr2_183901778_183902686 | 1.50 |
NCKAP1 |
NCK-associated protein 1 |
968 |
0.52 |
chr12_96183483_96184147 | 1.50 |
NTN4 |
netrin 4 |
89 |
0.96 |
chr4_41215795_41216596 | 1.49 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
280 |
0.92 |
chr19_34012221_34012739 | 1.48 |
PEPD |
peptidase D |
214 |
0.96 |
chr18_18821322_18821969 | 1.48 |
GREB1L |
growth regulation by estrogen in breast cancer-like |
558 |
0.83 |
chr3_180397078_180397946 | 1.47 |
CCDC39 |
coiled-coil domain containing 39 |
224 |
0.65 |
chr7_55087572_55088165 | 1.47 |
EGFR |
epidermal growth factor receptor |
1057 |
0.68 |
chr11_101453910_101454212 | 1.46 |
TRPC6 |
transient receptor potential cation channel, subfamily C, member 6 |
173 |
0.97 |
chr4_1166163_1166316 | 1.46 |
SPON2 |
spondin 2, extracellular matrix protein |
422 |
0.75 |
chrX_3263508_3263724 | 1.45 |
MXRA5 |
matrix-remodelling associated 5 |
1066 |
0.64 |
chr3_192126971_192127690 | 1.45 |
FGF12 |
fibroblast growth factor 12 |
492 |
0.87 |
chr17_5403222_5403521 | 1.45 |
MIS12 |
MIS12 kinetochore complex component |
13124 |
0.12 |
chr3_65535011_65535182 | 1.45 |
MAGI1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
48314 |
0.19 |
chr11_132934198_132934477 | 1.44 |
OPCML |
opioid binding protein/cell adhesion molecule-like |
120674 |
0.06 |
chr2_17719788_17720723 | 1.44 |
VSNL1 |
visinin-like 1 |
138 |
0.97 |
chr16_49888604_49888984 | 1.44 |
ZNF423 |
zinc finger protein 423 |
1252 |
0.55 |
chr19_3094656_3095580 | 1.44 |
GNA11 |
guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
710 |
0.53 |
chr15_68723961_68724170 | 1.44 |
ITGA11 |
integrin, alpha 11 |
427 |
0.9 |
chr7_155137180_155137645 | 1.43 |
BLACE |
B-cell acute lymphoblastic leukemia expressed |
23217 |
0.16 |
chr10_734574_734953 | 1.43 |
DIP2C |
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
843 |
0.59 |
chr1_33168198_33168349 | 1.43 |
SYNC |
syncoilin, intermediate filament protein |
88 |
0.96 |
chr14_73704441_73704760 | 1.43 |
PAPLN |
papilin, proteoglycan-like sulfated glycoprotein |
395 |
0.81 |
chr9_136858110_136858615 | 1.42 |
VAV2 |
vav 2 guanine nucleotide exchange factor |
636 |
0.73 |
chr17_79361447_79361695 | 1.42 |
RP11-1055B8.6 |
Uncharacterized protein |
7704 |
0.12 |
chr1_99127316_99128104 | 1.42 |
SNX7 |
sorting nexin 7 |
69 |
0.99 |
chr15_65669692_65670353 | 1.42 |
IGDCC3 |
immunoglobulin superfamily, DCC subclass, member 3 |
356 |
0.86 |
chr20_43374340_43375133 | 1.41 |
RP11-445H22.4 |
|
74 |
0.79 |
chr20_6103717_6104189 | 1.41 |
FERMT1 |
fermitin family member 1 |
238 |
0.95 |
chr2_20423382_20423908 | 1.41 |
SDC1 |
syndecan 1 |
396 |
0.84 |
chr7_29605545_29606286 | 1.40 |
PRR15 |
proline rich 15 |
849 |
0.6 |
chr2_241375743_241376138 | 1.40 |
GPC1 |
glypican 1 |
852 |
0.57 |
chr4_122685749_122685967 | 1.40 |
AC079341.1 |
Uncharacterized protein |
118 |
0.81 |
chr15_96897591_96898313 | 1.39 |
AC087477.1 |
Uncharacterized protein |
6535 |
0.18 |
chr10_33622786_33623487 | 1.39 |
NRP1 |
neuropilin 1 |
174 |
0.97 |
chr19_55598141_55598647 | 1.39 |
EPS8L1 |
EPS8-like 1 |
6634 |
0.1 |
chr3_190580567_190581193 | 1.39 |
GMNC |
geminin coiled-coil domain containing |
476 |
0.9 |
chr8_49292805_49293034 | 1.39 |
ENSG00000252710 |
. |
72329 |
0.13 |
chr10_43332530_43332765 | 1.39 |
ENSG00000252416 |
. |
4649 |
0.25 |
chr13_44947783_44948184 | 1.39 |
SERP2 |
stress-associated endoplasmic reticulum protein family member 2 |
5 |
0.99 |
chr7_140774038_140774471 | 1.38 |
TMEM178B |
transmembrane protein 178B |
222 |
0.94 |
chr10_134000904_134001312 | 1.38 |
DPYSL4 |
dihydropyrimidinase-like 4 |
704 |
0.64 |
chr17_40834675_40835133 | 1.38 |
CCR10 |
chemokine (C-C motif) receptor 10 |
178 |
0.59 |
chrX_153686737_153687403 | 1.38 |
PLXNA3 |
plexin A3 |
449 |
0.6 |
chr6_35464523_35464729 | 1.38 |
TEAD3 |
TEA domain family member 3 |
101 |
0.96 |
chr3_56501877_56502361 | 1.38 |
ERC2 |
ELKS/RAB6-interacting/CAST family member 2 |
272 |
0.95 |
chr1_32083419_32083832 | 1.38 |
HCRTR1 |
hypocretin (orexin) receptor 1 |
324 |
0.83 |
chr1_218520059_218520798 | 1.38 |
TGFB2 |
transforming growth factor, beta 2 |
851 |
0.54 |
chr11_111169649_111170452 | 1.38 |
COLCA2 |
colorectal cancer associated 2 |
74 |
0.88 |
chr10_118896728_118897230 | 1.38 |
VAX1 |
ventral anterior homeobox 1 |
588 |
0.73 |
chr16_86602293_86602507 | 1.38 |
RP11-463O9.5 |
|
1033 |
0.41 |
chr5_2752285_2752739 | 1.37 |
C5orf38 |
chromosome 5 open reading frame 38 |
133 |
0.91 |
chr22_31218163_31218918 | 1.37 |
OSBP2 |
oxysterol binding protein 2 |
37 |
0.98 |
chr5_132149652_132150157 | 1.37 |
SOWAHA |
sosondowah ankyrin repeat domain family member A |
871 |
0.46 |
chr4_174450759_174451005 | 1.37 |
HAND2 |
heart and neural crest derivatives expressed 2 |
498 |
0.55 |
chr17_13503949_13504100 | 1.36 |
HS3ST3A1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
1220 |
0.59 |
chr1_170633420_170634117 | 1.36 |
PRRX1 |
paired related homeobox 1 |
690 |
0.8 |
chr11_27015640_27015894 | 1.36 |
FIBIN |
fin bud initiation factor homolog (zebrafish) |
139 |
0.98 |
chr10_88728248_88728709 | 1.36 |
ADIRF |
adipogenesis regulatory factor |
289 |
0.5 |
chr4_5709733_5710324 | 1.36 |
EVC2 |
Ellis van Creveld syndrome 2 |
266 |
0.93 |
chr9_109625378_109625771 | 1.36 |
ZNF462 |
zinc finger protein 462 |
127 |
0.97 |
chr11_111848035_111848630 | 1.35 |
DIXDC1 |
DIX domain containing 1 |
299 |
0.84 |
chr1_42128153_42128566 | 1.35 |
HIVEP3 |
human immunodeficiency virus type I enhancer binding protein 3 |
38313 |
0.19 |
chr8_22409217_22409843 | 1.35 |
SORBS3 |
sorbin and SH3 domain containing 3 |
322 |
0.81 |
chr10_15411519_15412658 | 1.35 |
FAM171A1 |
family with sequence similarity 171, member A1 |
970 |
0.7 |
chr11_35640577_35641198 | 1.35 |
FJX1 |
four jointed box 1 (Drosophila) |
1152 |
0.57 |
chr3_123168721_123169253 | 1.35 |
ADCY5 |
adenylate cyclase 5 |
382 |
0.9 |
chr2_127977412_127977708 | 1.35 |
CYP27C1 |
cytochrome P450, family 27, subfamily C, polypeptide 1 |
94 |
0.98 |
chr19_13616854_13617049 | 1.34 |
CACNA1A |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
87 |
0.98 |
chr13_95619763_95620412 | 1.34 |
ENSG00000252335 |
. |
51402 |
0.18 |
chr10_121411714_121411984 | 1.34 |
BAG3 |
BCL2-associated athanogene 3 |
967 |
0.62 |
chr2_224903530_224903917 | 1.34 |
SERPINE2 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
202 |
0.96 |
chr1_208132304_208132634 | 1.34 |
CD34 |
CD34 molecule |
47722 |
0.19 |
chr21_42540300_42540728 | 1.34 |
BACE2 |
beta-site APP-cleaving enzyme 2 |
786 |
0.44 |
chr15_47476270_47477144 | 1.33 |
SEMA6D |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
409 |
0.87 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
2.1 | 6.4 | GO:0060677 | ureteric bud elongation(GO:0060677) |
2.0 | 6.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
2.0 | 4.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.7 | 5.2 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
1.6 | 3.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
1.6 | 1.6 | GO:0060594 | mammary gland specification(GO:0060594) |
1.5 | 1.5 | GO:0072007 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
1.4 | 1.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.4 | 5.7 | GO:0070141 | response to UV-A(GO:0070141) |
1.4 | 2.8 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.4 | 4.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.4 | 2.7 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
1.3 | 4.0 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
1.3 | 6.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.3 | 4.0 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
1.3 | 4.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
1.3 | 5.2 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
1.3 | 5.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.3 | 3.9 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.2 | 3.7 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.2 | 4.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.2 | 3.5 | GO:0060596 | mammary placode formation(GO:0060596) |
1.2 | 3.5 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
1.1 | 2.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.1 | 1.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.1 | 2.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
1.1 | 4.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.0 | 3.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
1.0 | 1.0 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
1.0 | 4.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
1.0 | 2.0 | GO:0042637 | catagen(GO:0042637) |
1.0 | 3.0 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.0 | 1.9 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
1.0 | 2.9 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.9 | 2.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.9 | 2.7 | GO:0034201 | response to oleic acid(GO:0034201) |
0.9 | 2.7 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.9 | 2.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.8 | 1.7 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.8 | 0.8 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.8 | 1.7 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.8 | 2.5 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.8 | 2.5 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.8 | 1.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.8 | 2.4 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.8 | 2.4 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.8 | 2.3 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.8 | 3.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.7 | 2.2 | GO:0021546 | rhombomere development(GO:0021546) |
0.7 | 1.5 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.7 | 0.7 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.7 | 2.9 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.7 | 5.0 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.7 | 2.8 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.7 | 2.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.7 | 4.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.7 | 1.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.7 | 2.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.7 | 2.8 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.7 | 2.7 | GO:0055026 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.7 | 6.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.7 | 2.7 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.7 | 2.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 2.0 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.7 | 1.3 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.7 | 6.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.6 | 1.9 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 1.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.6 | 1.9 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.6 | 1.9 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 1.9 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.6 | 2.5 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.6 | 3.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.6 | 1.9 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.6 | 1.9 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.6 | 3.1 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.6 | 0.6 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.6 | 3.0 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.6 | 5.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.6 | 2.4 | GO:0008218 | bioluminescence(GO:0008218) |
0.6 | 3.6 | GO:0001945 | lymph vessel development(GO:0001945) |
0.6 | 2.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.6 | 0.6 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.6 | 1.8 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.6 | 2.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.6 | 1.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 2.3 | GO:0051938 | L-glutamate import(GO:0051938) |
0.6 | 1.2 | GO:0072070 | loop of Henle development(GO:0072070) |
0.6 | 1.7 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.6 | 2.9 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.6 | 0.6 | GO:0060192 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.6 | 1.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.6 | 1.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.6 | 1.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.6 | 2.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.6 | 1.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.6 | 3.4 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.6 | 0.6 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.6 | 1.7 | GO:0010842 | retina layer formation(GO:0010842) |
0.6 | 7.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.5 | 2.2 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.5 | 1.1 | GO:0021894 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.5 | 2.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.5 | 2.7 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.5 | 1.1 | GO:0060013 | righting reflex(GO:0060013) |
0.5 | 5.8 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.5 | 2.1 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.5 | 1.6 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.5 | 1.6 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.5 | 3.0 | GO:0031641 | regulation of myelination(GO:0031641) |
0.5 | 0.5 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.5 | 2.0 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.5 | 3.5 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.5 | 4.0 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.5 | 3.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.5 | 1.5 | GO:0034653 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.5 | 1.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.5 | 1.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.5 | 4.3 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.5 | 1.9 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.5 | 0.5 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.5 | 2.9 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.5 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.5 | 2.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.5 | 8.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.5 | 1.4 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.5 | 0.9 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.5 | 1.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.5 | 0.9 | GO:1903579 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.5 | 2.8 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.5 | 1.8 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.5 | 0.5 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.5 | 0.5 | GO:0021783 | midbrain-hindbrain boundary morphogenesis(GO:0021555) preganglionic parasympathetic fiber development(GO:0021783) regulation of timing of neuron differentiation(GO:0060164) |
0.5 | 0.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.5 | 3.6 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.4 | 1.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.4 | 2.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 1.8 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.4 | 2.6 | GO:0045217 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.4 | 1.3 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.4 | 3.0 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.4 | 1.3 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.4 | 2.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.4 | 6.8 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.4 | 1.7 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.4 | 0.4 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.4 | 0.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.4 | 1.2 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.4 | 0.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 1.2 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.4 | 4.1 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.4 | 5.3 | GO:0048286 | lung alveolus development(GO:0048286) |
0.4 | 2.0 | GO:0060009 | Sertoli cell differentiation(GO:0060008) Sertoli cell development(GO:0060009) |
0.4 | 0.8 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.4 | 1.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 3.2 | GO:0006911 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.4 | 0.4 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) |
0.4 | 6.7 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.4 | 1.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 1.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 0.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 0.4 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.4 | 1.9 | GO:0008347 | glial cell migration(GO:0008347) |
0.4 | 1.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 1.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.4 | 0.4 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.4 | 0.4 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.4 | 0.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.4 | 1.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.4 | 0.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.4 | 1.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.4 | 1.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.4 | 1.9 | GO:0048675 | axon extension(GO:0048675) neuron projection extension(GO:1990138) |
0.4 | 1.5 | GO:0097531 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.4 | 1.1 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) positive regulation of tooth mineralization(GO:0070172) |
0.4 | 1.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.4 | 2.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 0.7 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.4 | 0.7 | GO:0022038 | corpus callosum development(GO:0022038) |
0.4 | 1.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.4 | 0.7 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.4 | 2.5 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.4 | 0.4 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.4 | 0.7 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.4 | 1.8 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.4 | 0.7 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.4 | 1.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.4 | 0.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 0.4 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.4 | 1.8 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.3 | 0.7 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.3 | 3.8 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.3 | 0.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 2.0 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 1.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 1.7 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.3 | 0.7 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.3 | 1.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.3 | 0.7 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.3 | 1.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.3 | 5.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.3 | 1.0 | GO:0090026 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.3 | 0.7 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.3 | 0.3 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.3 | 1.0 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.3 | 3.9 | GO:0008038 | neuron recognition(GO:0008038) |
0.3 | 1.0 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.3 | 5.8 | GO:0007566 | embryo implantation(GO:0007566) |
0.3 | 0.6 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 0.6 | GO:0050932 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.3 | 0.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.3 | 0.3 | GO:0060346 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.3 | 1.9 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.3 | 0.9 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 0.9 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.3 | 0.6 | GO:0022605 | oogenesis stage(GO:0022605) |
0.3 | 1.8 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.3 | 1.2 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.3 | 0.9 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 1.2 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.3 | 0.6 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.3 | 4.8 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.3 | 0.6 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.3 | 0.9 | GO:0008049 | male courtship behavior(GO:0008049) |
0.3 | 0.9 | GO:0051593 | response to folic acid(GO:0051593) |
0.3 | 0.6 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.3 | 1.8 | GO:0031529 | ruffle organization(GO:0031529) |
0.3 | 0.9 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.3 | 0.3 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 2.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.3 | 0.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.3 | 5.8 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.3 | 0.3 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.3 | 0.9 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 1.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.3 | 0.3 | GO:1904063 | negative regulation of cation transmembrane transport(GO:1904063) |
0.3 | 0.8 | GO:0044273 | sulfur amino acid catabolic process(GO:0000098) sulfur compound catabolic process(GO:0044273) |
0.3 | 1.4 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.3 | 0.3 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.3 | 0.8 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.3 | 1.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 4.1 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.3 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.3 | 0.3 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.3 | 2.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.3 | 0.5 | GO:0090102 | cochlea development(GO:0090102) |
0.3 | 0.8 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.3 | 2.7 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.3 | 0.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.3 | 1.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 0.8 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.3 | 0.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.3 | 2.4 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.3 | 0.3 | GO:0048806 | genitalia development(GO:0048806) |
0.3 | 0.8 | GO:0035094 | response to nicotine(GO:0035094) |
0.3 | 1.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.3 | GO:0051446 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.3 | 0.8 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.3 | 1.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 0.8 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.3 | 0.3 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.3 | 0.3 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.3 | 1.0 | GO:0007616 | long-term memory(GO:0007616) |
0.3 | 1.0 | GO:0071800 | podosome assembly(GO:0071800) |
0.3 | 0.8 | GO:0071436 | sodium ion export(GO:0071436) |
0.3 | 2.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.3 | 0.5 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.2 | 0.7 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.2 | 0.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.2 | GO:0032095 | regulation of response to food(GO:0032095) |
0.2 | 1.5 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.2 | 2.4 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.2 | 0.7 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 2.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 0.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 1.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 0.7 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.2 | 0.2 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.2 | 0.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 1.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.2 | 1.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.9 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.2 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.2 | 8.7 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.2 | 1.6 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 0.5 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.2 | 0.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 2.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 27.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 4.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 0.7 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.2 | 2.0 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 0.4 | GO:0060438 | trachea development(GO:0060438) |
0.2 | 0.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 0.4 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 1.6 | GO:0048265 | response to pain(GO:0048265) |
0.2 | 0.9 | GO:0060350 | endochondral bone morphogenesis(GO:0060350) |
0.2 | 0.7 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 0.7 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 1.8 | GO:0007567 | parturition(GO:0007567) |
0.2 | 1.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.9 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.2 | 0.2 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.2 | 1.9 | GO:0030318 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
0.2 | 1.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 0.4 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.2 | 2.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.2 | 0.4 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.2 | 1.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.2 | GO:0043090 | amino acid import(GO:0043090) |
0.2 | 0.6 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 0.4 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.2 | 1.4 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.2 | 0.8 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.2 | 1.4 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.2 | 0.6 | GO:0034393 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 1.8 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.2 | 0.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.6 | GO:0060840 | artery development(GO:0060840) |
0.2 | 0.2 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.2 | 1.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.2 | 0.2 | GO:0010269 | response to selenium ion(GO:0010269) |
0.2 | 1.0 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.2 | 0.2 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.2 | 1.3 | GO:0002021 | response to dietary excess(GO:0002021) |
0.2 | 4.6 | GO:0001764 | neuron migration(GO:0001764) |
0.2 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 1.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.2 | 0.6 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.2 | 0.6 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.6 | GO:0046475 | phosphatidylcholine catabolic process(GO:0034638) glycerophospholipid catabolic process(GO:0046475) |
0.2 | 0.2 | GO:0046083 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.2 | 0.2 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.2 | 0.9 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 38.9 | GO:0097485 | axon guidance(GO:0007411) neuron projection guidance(GO:0097485) |
0.2 | 0.6 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.2 | 0.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 2.2 | GO:0032400 | melanosome localization(GO:0032400) |
0.2 | 1.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 2.8 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.2 | 0.2 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.2 | 1.6 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.2 | 0.5 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.2 | 0.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 0.4 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.2 | 0.5 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 0.5 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.2 | 0.7 | GO:0045008 | depyrimidination(GO:0045008) |
0.2 | 0.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.2 | 0.7 | GO:0090505 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.2 | 11.0 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.2 | 1.0 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.2 | 0.7 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 0.7 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.2 | 1.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 0.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 0.5 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.2 | 0.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.7 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.2 | 0.3 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.2 | 0.3 | GO:0043113 | receptor clustering(GO:0043113) |
0.2 | 0.3 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.2 | 0.2 | GO:0015840 | urea transport(GO:0015840) |
0.2 | 1.0 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.2 | 0.3 | GO:0010171 | body morphogenesis(GO:0010171) |
0.2 | 0.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.6 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.2 | 0.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.2 | 1.1 | GO:0070875 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.2 | 0.5 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 4.9 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.2 | 0.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.2 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.2 | 0.9 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.2 | 2.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 0.5 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.2 | 0.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.5 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.2 | 0.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 0.6 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.5 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.2 | 0.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.8 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.2 | 0.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.3 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
0.2 | 2.0 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) |
0.2 | 0.6 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.4 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.1 | 0.1 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.1 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.3 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.7 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.1 | 0.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.1 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 2.5 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.1 | 2.5 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.1 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.1 | 1.3 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.1 | 0.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 1.9 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.7 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) negative regulation of dendrite development(GO:2000171) |
0.1 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.4 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.6 | GO:0007549 | dosage compensation(GO:0007549) |
0.1 | 0.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.5 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.1 | 0.8 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.1 | 1.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.5 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.1 | 0.5 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 1.2 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.1 | 0.9 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 0.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.1 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.9 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 2.6 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.1 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.1 | 1.0 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 1.0 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.4 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.9 | GO:1900076 | regulation of insulin receptor signaling pathway(GO:0046626) regulation of cellular response to insulin stimulus(GO:1900076) |
0.1 | 0.1 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.1 | 0.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.6 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.2 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.1 | 0.9 | GO:0033189 | response to vitamin A(GO:0033189) |
0.1 | 0.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 8.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 1.0 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 1.3 | GO:0051017 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.1 | 0.2 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.1 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.1 | 0.6 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.2 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.1 | GO:0009261 | ribonucleotide catabolic process(GO:0009261) |
0.1 | 1.9 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.4 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 1.4 | GO:0009310 | amine catabolic process(GO:0009310) cellular biogenic amine catabolic process(GO:0042402) |
0.1 | 1.5 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.6 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 0.2 | GO:0048935 | peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 0.4 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.4 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.2 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.1 | 0.5 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.3 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.7 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
0.1 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.5 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.9 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.1 | GO:0044259 | multicellular organismal macromolecule metabolic process(GO:0044259) |
0.1 | 0.9 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.1 | 0.1 | GO:0002669 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.3 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.3 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 0.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.5 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.2 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.2 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.1 | 0.4 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.1 | 0.1 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.6 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.2 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.1 | 0.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.3 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.5 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 2.1 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.1 | 0.4 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 1.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.3 | GO:0003097 | renal water transport(GO:0003097) renal water absorption(GO:0070295) |
0.1 | 0.2 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.5 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 0.7 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.7 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.2 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.1 | 0.1 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.1 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 2.4 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.1 | 0.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.3 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.1 | 0.1 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.1 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 1.4 | GO:0035195 | gene silencing by miRNA(GO:0035195) |
0.1 | 0.5 | GO:0007492 | endoderm development(GO:0007492) |
0.1 | 0.2 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.2 | GO:0010092 | organ induction(GO:0001759) specification of organ identity(GO:0010092) |
0.1 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.7 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 1.3 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.1 | 0.2 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.6 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0003279 | cardiac septum development(GO:0003279) |
0.1 | 1.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 0.5 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.1 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.3 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.3 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.1 | 0.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.3 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.1 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.1 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.3 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 0.3 | GO:0009750 | response to fructose(GO:0009750) |
0.1 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.5 | GO:0016358 | dendrite development(GO:0016358) |
0.1 | 0.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.2 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.1 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 1.6 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.2 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.1 | 0.3 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.1 | 0.1 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.3 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.5 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.5 | GO:0061462 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.1 | 0.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 1.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.1 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.2 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.1 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.1 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.1 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 1.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.2 | GO:0019731 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 2.2 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.1 | 5.9 | GO:0001501 | skeletal system development(GO:0001501) |
0.1 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.2 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.1 | 1.2 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
0.1 | 1.4 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 1.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.1 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.1 | 0.1 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.6 | GO:0046503 | glycerolipid catabolic process(GO:0046503) |
0.1 | 0.1 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.1 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.5 | GO:0035113 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.1 | 0.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 0.1 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.1 | 0.3 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 0.1 | GO:0098754 | detoxification(GO:0098754) |
0.1 | 0.2 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.4 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.1 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 0.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 6.1 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 0.5 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.7 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.1 | 7.9 | GO:0006813 | potassium ion transport(GO:0006813) |
0.1 | 0.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.1 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.1 | 0.1 | GO:0072075 | kidney mesenchyme development(GO:0072074) metanephric mesenchyme development(GO:0072075) |
0.1 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 1.0 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.1 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 0.1 | GO:0010559 | regulation of glycoprotein biosynthetic process(GO:0010559) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.1 | GO:1904377 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.1 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.7 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.2 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.1 | 0.4 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.3 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.1 | 0.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.5 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.2 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.1 | 0.6 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.5 | GO:0009855 | determination of bilateral symmetry(GO:0009855) |
0.1 | 0.4 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.0 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.0 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.0 | 0.1 | GO:0090151 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.0 | 0.1 | GO:0097435 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.0 | 1.3 | GO:0001822 | kidney development(GO:0001822) |
0.0 | 0.1 | GO:0061515 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.2 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.6 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.0 | 0.9 | GO:0007626 | locomotory behavior(GO:0007626) |
0.0 | 3.3 | GO:0007517 | muscle organ development(GO:0007517) |
0.0 | 0.0 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.3 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.2 | GO:0006188 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.0 | 0.0 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.0 | 0.3 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.0 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) regulation of neurotransmitter transport(GO:0051588) |
0.0 | 0.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.0 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.0 | 0.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.0 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.0 | 0.0 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 1.6 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) positive regulation of calcium ion import(GO:0090280) |
0.0 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
0.0 | 0.5 | GO:0038061 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.0 | GO:1902224 | cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0048738 | cardiac muscle tissue development(GO:0048738) |
0.0 | 0.0 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.0 | 0.5 | GO:0043588 | skin development(GO:0043588) |
0.0 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 1.8 | GO:0034329 | cell junction assembly(GO:0034329) |
0.0 | 0.2 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.1 | GO:0048538 | thymus development(GO:0048538) |
0.0 | 0.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.4 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.0 | GO:0035590 | purinergic receptor signaling pathway(GO:0035587) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.4 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.1 | GO:0033555 | multicellular organismal response to stress(GO:0033555) |
0.0 | 0.0 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.0 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.1 | GO:0015853 | adenine transport(GO:0015853) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.2 | GO:0050848 | regulation of calcium-mediated signaling(GO:0050848) |
0.0 | 0.0 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) labyrinthine layer morphogenesis(GO:0060713) |
0.0 | 0.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.0 | 0.0 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.1 | GO:0048489 | synaptic vesicle transport(GO:0048489) synaptic vesicle localization(GO:0097479) establishment of synaptic vesicle localization(GO:0097480) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.2 | GO:0006900 | membrane budding(GO:0006900) vesicle coating(GO:0006901) single-organism membrane budding(GO:1902591) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.2 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.1 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.0 | 1.0 | GO:0008544 | epidermis development(GO:0008544) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.2 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.0 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.1 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.0 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.1 | GO:0071450 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.5 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.2 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.3 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.0 | 0.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.2 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.0 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.0 | 0.0 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 0.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.0 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.0 | 0.0 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.6 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 2.0 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.0 | GO:0001554 | luteolysis(GO:0001554) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.0 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.3 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.0 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.0 | GO:0033079 | immature T cell proliferation(GO:0033079) |
0.0 | 0.3 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.2 | GO:1901800 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.0 | GO:0010611 | regulation of cardiac muscle hypertrophy(GO:0010611) |
0.0 | 0.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.1 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.0 | 0.0 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.1 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.0 | 0.9 | GO:0006887 | exocytosis(GO:0006887) |
0.0 | 0.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.0 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.0 | GO:0072663 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.0 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.3 | 1.3 | GO:0043260 | laminin-11 complex(GO:0043260) |
1.0 | 5.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.0 | 2.9 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.9 | 2.7 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.8 | 0.8 | GO:0016460 | myosin II complex(GO:0016460) |
0.8 | 2.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.8 | 4.9 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.8 | 4.6 | GO:0010369 | chromocenter(GO:0010369) |
0.8 | 2.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.7 | 2.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.7 | 3.3 | GO:0071437 | invadopodium(GO:0071437) |
0.6 | 1.9 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.6 | 1.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.6 | 2.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.6 | 2.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.6 | 0.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.6 | 1.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 5.9 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.5 | 1.0 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.5 | 2.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 1.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.5 | 3.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 4.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.5 | 2.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.5 | 3.9 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.5 | 4.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.5 | 1.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 6.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.5 | 1.8 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.4 | 1.3 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 1.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.4 | 2.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.4 | 3.4 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.4 | 1.3 | GO:0032449 | CBM complex(GO:0032449) |
0.4 | 4.6 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.4 | 8.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 6.1 | GO:0031256 | leading edge membrane(GO:0031256) |
0.4 | 0.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 1.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.4 | 0.4 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.4 | 1.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 6.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 1.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 24.8 | GO:0060076 | excitatory synapse(GO:0060076) |
0.3 | 42.1 | GO:0005912 | adherens junction(GO:0005912) |
0.3 | 0.6 | GO:0043034 | costamere(GO:0043034) |
0.3 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 10.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 0.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 7.7 | GO:0030018 | Z disc(GO:0030018) |
0.3 | 10.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.3 | 5.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 14.3 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 71.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.3 | 3.4 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 2.2 | GO:0030315 | T-tubule(GO:0030315) |
0.3 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 1.0 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 1.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 1.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 1.6 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 0.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 1.5 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 1.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 8.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 1.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 1.2 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 0.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 25.5 | GO:0005911 | cell-cell junction(GO:0005911) |
0.2 | 0.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 0.7 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 5.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 1.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.2 | 2.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 1.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 1.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 0.8 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 2.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 12.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.2 | 7.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 2.0 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.1 | 13.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.6 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 2.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 1.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.3 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 6.8 | GO:0044449 | contractile fiber part(GO:0044449) |
0.1 | 2.1 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.0 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.1 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 1.6 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 0.7 | GO:0044456 | synapse part(GO:0044456) |
0.1 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 0.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.8 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 9.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.8 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 1.2 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.1 | 0.2 | GO:0043656 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 1.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.3 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.1 | 0.5 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.1 | 2.4 | GO:0005903 | brush border(GO:0005903) |
0.1 | 13.1 | GO:0030054 | cell junction(GO:0030054) |
0.1 | 4.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.4 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 1.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.1 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 0.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 5.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.4 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 18.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 1.0 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.1 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 0.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 105.7 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 0.5 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 3.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 0.2 | GO:0070938 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.1 | 0.7 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 3.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 1.0 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.2 | GO:0098799 | mitochondrial outer membrane translocase complex(GO:0005742) outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.0 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 30.4 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 1.3 | GO:0009295 | nucleoid(GO:0009295) |
0.0 | 0.2 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 0.0 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 1.5 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 1.2 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 2.8 | GO:0005792 | obsolete microsome(GO:0005792) |
0.0 | 0.3 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.3 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 1.0 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 1.0 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.6 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 1.0 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 1.6 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.2 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.0 | 0.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.5 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 1.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.4 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.1 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 72.9 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.2 | GO:0022624 | proteasome regulatory particle(GO:0005838) proteasome accessory complex(GO:0022624) |
0.0 | 0.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.0 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.1 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.5 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.1 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.6 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.5 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 1.5 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.0 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.6 | 4.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.4 | 1.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
1.3 | 1.3 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
1.3 | 13.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.2 | 6.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.2 | 4.8 | GO:0048495 | Roundabout binding(GO:0048495) |
1.1 | 1.1 | GO:0043559 | insulin binding(GO:0043559) |
1.1 | 6.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.1 | 3.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
1.0 | 3.0 | GO:0005113 | patched binding(GO:0005113) |
0.9 | 0.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.8 | 3.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.8 | 2.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.8 | 2.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.8 | 2.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.8 | 2.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.8 | 2.4 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.8 | 3.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.8 | 5.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.8 | 3.0 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.7 | 3.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.7 | 6.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.7 | 2.9 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.7 | 1.4 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.7 | 3.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.7 | 2.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.7 | 11.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.7 | 2.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.7 | 4.7 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.6 | 1.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.6 | 3.8 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.6 | 1.9 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.6 | 1.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.6 | 6.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 1.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 1.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.6 | 3.1 | GO:0009374 | biotin binding(GO:0009374) |
0.6 | 2.4 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 3.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.6 | 1.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.6 | 2.9 | GO:0005499 | vitamin D binding(GO:0005499) |
0.6 | 1.7 | GO:0008061 | chitin binding(GO:0008061) |
0.6 | 1.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.5 | 2.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.5 | 2.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.5 | 1.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 1.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.5 | 1.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 2.0 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.5 | 2.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 5.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.5 | 8.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.5 | 1.0 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.5 | 2.0 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.5 | 1.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.5 | 1.4 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.5 | 2.4 | GO:0051192 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.5 | 1.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 1.4 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.4 | 3.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 1.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 2.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.4 | 3.5 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.4 | 1.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 0.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 4.8 | GO:0030553 | cGMP binding(GO:0030553) |
0.4 | 1.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.4 | 0.9 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.4 | 1.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 1.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.4 | 1.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.4 | 0.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 1.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 0.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.4 | 2.4 | GO:0048185 | activin binding(GO:0048185) |
0.4 | 1.2 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.4 | 2.0 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.4 | 1.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.4 | 2.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 5.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.4 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 1.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.4 | 1.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 3.0 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.4 | 7.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 2.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.4 | 1.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 1.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.4 | 1.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 1.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.4 | 1.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.4 | 1.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.4 | 3.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.4 | 1.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.4 | 1.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 2.5 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.3 | 1.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.3 | 1.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 4.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.3 | 1.4 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.3 | 1.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 23.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 3.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 0.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.3 | 1.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 10.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.3 | 1.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 1.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 1.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 2.8 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 2.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 3.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 1.5 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.3 | 6.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 1.2 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.3 | 0.9 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.3 | 3.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.3 | 4.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.3 | 0.9 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.3 | 0.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 1.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 6.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 1.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 1.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 2.0 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 2.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 4.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 1.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 0.6 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 0.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.3 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 0.8 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 6.8 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 2.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 2.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 1.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 0.8 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.3 | 4.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 1.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 0.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 1.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 1.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 0.7 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.7 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 1.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 0.5 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.2 | 1.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 2.2 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.2 | 3.8 | GO:0022839 | calcium activated cation channel activity(GO:0005227) ion gated channel activity(GO:0022839) |
0.2 | 16.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.9 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.2 | 0.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 0.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 0.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 3.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 1.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 0.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 0.4 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.2 | 0.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 0.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 4.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.8 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 21.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 1.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 1.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 2.2 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 1.8 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 1.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 0.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 1.0 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 3.8 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 1.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 1.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 2.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.4 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 0.4 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 0.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 1.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.7 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.2 | 0.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.2 | 1.8 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 0.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 4.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 0.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.5 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 2.5 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 1.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 0.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 0.7 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 0.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 2.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 3.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 2.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 0.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 1.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 2.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 2.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 1.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 1.9 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 0.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 0.5 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.2 | 1.7 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.2 | 0.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 3.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.2 | 0.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 1.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 1.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 1.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.2 | 0.2 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.2 | 2.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 0.5 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.2 | 0.5 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 1.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 45.0 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.2 | 0.2 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 1.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 2.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.9 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 0.8 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.2 | 0.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 0.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 1.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.2 | 1.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.2 | 0.8 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.2 | 2.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.8 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 2.6 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 6.8 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 8.6 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.1 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.4 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.1 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.7 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.1 | 0.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 1.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 1.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 13.9 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 2.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.5 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 2.2 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.1 | 1.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 3.0 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.4 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 1.9 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 7.9 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.8 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 2.9 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.1 | 0.3 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 1.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.3 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.7 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.2 | GO:0043176 | amine binding(GO:0043176) |
0.1 | 0.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.5 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.4 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.8 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.7 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 5.9 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 0.7 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.9 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 1.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 1.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 1.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 2.3 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 6.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 1.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 2.9 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 1.3 | GO:0070405 | ammonium ion binding(GO:0070405) |
0.1 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 2.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.6 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.1 | 0.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.2 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.2 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.1 | 2.4 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.6 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.4 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 2.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 1.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 1.1 | GO:0042562 | hormone binding(GO:0042562) |
0.1 | 0.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 2.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.8 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 2.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 1.6 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.3 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 0.5 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.1 | 0.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.4 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.3 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 5.4 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 1.0 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.1 | 11.3 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 2.2 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 1.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.5 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.1 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 11.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.6 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.1 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.5 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 1.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 3.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.2 | GO:0046980 | tapasin binding(GO:0046980) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.6 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.4 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 2.4 | GO:0008528 | G-protein coupled peptide receptor activity(GO:0008528) |
0.0 | 0.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.4 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 1.0 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.3 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.2 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 1.8 | GO:0042277 | peptide binding(GO:0042277) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.2 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.0 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 1.4 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.6 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 2.5 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 17.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.3 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.6 | GO:0017016 | Ras GTPase binding(GO:0017016) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.0 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.0 | 0.1 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 1.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 1.2 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.2 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 5.9 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 0.3 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.0 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.0 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.6 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 1.4 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.0 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.5 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.0 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 1.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.0 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.0 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 25.0 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.5 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.1 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.2 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.0 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.0 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 1.4 | GO:0017171 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
0.0 | 0.4 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 1.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 11.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.8 | 31.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.7 | 6.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 7.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 13.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 4.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 13.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.4 | 5.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 2.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 15.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.4 | 7.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 10.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.4 | 9.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 5.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 9.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 0.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 5.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 7.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 39.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 10.3 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 0.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 1.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 2.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 8.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 1.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 6.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 3.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 0.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 8.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 4.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 5.8 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.2 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 5.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 9.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 1.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 1.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 4.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 3.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 22.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 3.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 30.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 3.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 1.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 26.2 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.1 | 1.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 0.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 2.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 3.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.7 | 0.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.7 | 8.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.7 | 8.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.6 | 0.6 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.6 | 21.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.6 | 6.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.5 | 17.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 14.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.5 | 5.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 5.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.5 | 1.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.5 | 6.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.5 | 12.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 6.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 5.9 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.4 | 5.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 8.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 14.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 4.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 2.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 5.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 0.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.3 | 3.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 3.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 2.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 4.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 3.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 2.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 3.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 4.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 2.0 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 0.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 5.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 5.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 1.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 2.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 2.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 3.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 4.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 1.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 1.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 1.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.2 | 10.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.2 | 0.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 7.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 1.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 0.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 10.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 1.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 1.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 1.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 3.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 2.9 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 0.5 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 9.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 4.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 2.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.4 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 2.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 4.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 4.9 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 1.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 1.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.9 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 1.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.3 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 1.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.3 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 1.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 0.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 3.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 3.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 16.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 1.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 3.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 4.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 2.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.6 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.6 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.1 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.4 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 0.5 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.0 | 0.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.3 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 3.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.1 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.0 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |